Furthermore, it has been recently reported that the NK-1 receptor antagonist aprepitant (a morpholine derivative) is a broad spectrum antitumor drug [24] and exerts an antitumor action against human malignant melanoma cell lines [8]. Here, TACR1 is linked to melanoma.